Crinetics Pharmaceuticals (CRNX) Amortizatization of Intangibles (2019 - 2026)

Crinetics Pharmaceuticals' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 49.27% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $13.3 million, a 14.17% decrease from a year earlier, with the FY2025 full-year figure at $15.4 million, up 3.31% from the prior year.
• Amortizatization of Intangibles declined to $2.2 million in Q1 2026 per CRNX's latest filing, from $2.7 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $4.7 million in Q2 2025 and bottomed at -$322000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $2.7 million (2025), against an average of $2.3 million.
• Across the five-year window, Amortizatization of Intangibles tumbled 287.95% in 2022 and surged 921.08% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $351000.0 in 2022, then jumped by 921.08% to $3.6 million in 2023, then gained by 16.16% to $4.2 million in 2024, then sank by 34.33% to $2.7 million in 2025, then slipped by 18.8% to $2.2 million in 2026.
• Per Business Quant, the three latest CRNX Amortizatization of Intangibles figures stand at $2.2 million (Q1 2026), $2.7 million (Q4 2025), and $3.6 million (Q3 2025).